Human papillomavirus (HPV) causes around 90% of cervical cancers, most anal and oropharyngeal cancers, and a substantial share of penile and vulvar cancers. Vaccinating before exposure produces extremely high effectiveness. Australia’s school program reaches Year 7 students with a single dose, but plenty of adults are not covered, or only partially.
Eligibility extended
ATAGI has progressively extended HPV vaccination upper-age recommendations to age 45 for most adults. Funding under the NIP is currently limited to people up to 26, with private vaccination available beyond that.
Who benefits
- Adults under 26 who missed Year 7, free under the NIP.
- Adults aged 26–45 who didn’t complete vaccination, private but evidence-supported.
- Men and women equally, HPV-related cancers affect both.
- Immunocompromised adults, who may benefit from boosters even after the routine schedule.
Does it help if I already have HPV?
Vaccination won’t treat current HPV infection or reverse cellular changes already present. But because there are many HPV types, vaccination still protects you against types you haven’t encountered. Talk to your GP if you’ve had abnormal Cervical Screening Test results.
Schedule
For adolescents, a single dose. For adults starting later or who are immunocompromised, three doses over six months. Your immuniser will confirm.
Sources & further reading
General information only. This article is educational and is not a substitute for personal medical advice. Your immuniser will confirm eligibility and contraindications on the day.
TGA advertising compliance. Vaccines are referred to by disease or category in line with the Therapeutic Goods Advertising Code. Specific brands and registered indications are discussed at the consultation.